is glp-1 safe for seniors Medications Infographic Scientists cautiously suggest GLP-1s are

10.1016/j.cger.2013.07.003 187 RocchiA.MorettiD.LignaniG.ColomboE.Scholz-StarkeJ.BaldelliP.et al

Common dose 200-300 mcg subQ nightly

Demand for GLP-1 Companion Products in the global market is estimated to be valued at USD 4.7 billion in 2025

Arch Intern Med 162(12):13491360 Yafi FA, Sharlip ID, Becher EF (2018) Update on the safety of phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction

Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide Novo Nordisk A new observational study reported for the first time a potential link between Novo Nordisks GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss

WO: HELSINGIN YLIOPISTO OP - FI 20205738 A